🔥🐔 BizChicken 🐔🔥
Companies Similar to Predictive Oncology Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
Fate Therapeutics, Inc.
programmed cellular immunotherapies
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its development programs include various NK- and T-cell immuno-oncology therapies targeting different cancers.
Vision/Values | About | Management | Directors | About | Contact
Symbol: FATE
Recent Price: $1.62
Industry: Biotechnology
CEO: Mr. J. Scott Wolchko
Sector: Healthcare
Employees: 181
Address: 12278 Scripps Summit Drive, San Diego, CA 92131
Phone: 858 875 1800
Leadership
- William Rastetter, Ph.D., Chairman
- John Mendlein, Ph.D., J.D., Vice Chairman
- Dr. Shefali Agarwal, Board Member
- Timothy P. Coughlin, Board Member
- Robert S. Epstein, M.D., Board Member
- Karin Jooss, Ph.D., Board Member
- Michael Lee, Board Member
- Neely Mozaffarian, M.D., Ph.D., FACR, Board Member
- Yuan Xu, Ph.D., Board Member
- Scott Wolchko, President & CEO
Last updated: 2024-12-31
Prelude Therapeutics Incorporated
PRT543
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company focusing on novel precision cancer medicines, including products like PRT543, PRT811, PRT1419, PRT2527, and others at various stages of development or trials.
About | Leadership | Directors | About | Contact | Contact | Careers | Careers | Jobs | About | About
Symbol: PRLD
Recent Price: $1.21
Industry: Biotechnology
CEO: Dr. Krishna Vaddi D.V.M., Ph.D.
Sector: Healthcare
Employees: 128
Address: 200 Powder Mill Road, Wilmington, DE 19803
Phone: 302 467 1280
Leadership
- Kris Vaddi, Ph.D., Chief Executive Officer
- Jane Huang, M.D., President and Chief Medical Officer
- Bryant Lim, Chief Legal Officer, Corporate Secretary & Interim Chief Financial Officer
- Andrew Combs, Ph.D., Chief Chemistry Officer
- Peggy Scherle, Ph.D., Chief Scientific Officer
- Michele Porreca, M.B.A., Chief People Officer
- Sean Brusky, M.B.A., Chief Business Officer
- Naveen Babbar, Ph.D., Senior Vice President, Translation Medicine
- Aimee Crombie, Ph.D., SVP & Head of Strategic Planning & Operations
- Robert Doody, Senior Vice President, Investor Relations
- Wan-Jen Hong, M.D., Senior Vice President, Clinical Development
- Bill Novotny, M.D., Senior Vice President, Clinical Development
- Madhu Pudipeddi, Ph.D., Senior Vice President, Technical Operations
- Paul A. Friedman, M.D., Chair
- David Bonita, M.D., Director
- Julian C. Baker, Director
- Mardi C. Dier, Director
- Victor Sandor, M.D., Director
- Martin Babler, Director
Last updated: 2024-12-31
Pyxis Oncology, Inc.
PYX-106, PYX-102, PYX-201, PYX-202, PYX-203
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.
Symbol: PYXS
Recent Price: $1.56
Industry: Biotechnology
CEO: Dr. Lara S. Sullivan M.D., MBA
Sector: Healthcare
Employees: 55
Address: 35 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 221 9059
Last updated: 2024-12-31
Acrivon Therapeutics, Inc. Common Stock
Acrivon Predictive Precision Proteomics
Acrivon Therapeutics is a clinical stage biopharmaceutical company developing oncology medicines using a proteomics-based platform to identify patient responders. Their lead candidate, ACR-368, is in Phase 2 trials for various cancers.
Symbol: ACRV
Recent Price: $5.41
Industry: Biotechnology
CEO: Dr. Peter Blume-Jensen M.D., Ph.D.
Sector: Healthcare
Employees: 58
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 617-207-8979
Last updated: 2024-12-31
Allogene Therapeutics, Inc.
UCART19
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer.
About | About | About | Contact | Contact | Careers | Careers | Jobs | About | About | About | About | About | About
Symbol: ALLO
Recent Price: $2.10
Industry: Biotechnology
CEO: Dr. David D. Chang M.D., Ph.D.
Sector: Healthcare
Employees: 232
Address: 210 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 457 2700
Last updated: 2024-12-31
ALX Oncology Holdings Inc.
ALX148
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.
About | Contact | About | About | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Careers | About | About | Careers | Jobs
Symbol: ALXO
Recent Price: $1.66
Industry: Biotechnology
CEO: Mr. Jason W. Lettmann
Sector: Healthcare
Employees: 81
Address: 323 Allerton Avenue, South San Francisco, CA 94080
Phone: 650 466 7125
Last updated: 2024-12-31
American Oncology Network, Inc.
Oncology Services
American Oncology Network, Inc. provides comprehensive oncology services, including laboratory, pathology, specialty pharmacy, and care management support services in the United States.
Symbol: AONC
Recent Price: $4.94
Industry: Medical - Care Facilities
CEO: Mr. Todd Schonherz
Sector: Healthcare
Employees: 1525
Address: 14543 Global Parkway, Fort Myers, FL 33913
Phone: 833-886-1725
Last updated: 2024-12-31
Apollomics, Inc.
APL-101 (Vebreltinib), APL-102, APL-122
Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.
Symbol: APLM
Recent Price: $10.13
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Sector: Healthcare
Employees: 45
Address: 989 East Hillsdale Blvd, Foster City, CA 94404
Phone: 650 209 4055
Last updated: 2024-12-31
Champions Oncology, Inc.
Tumorgraft Technology Platform
Champions Oncology, Inc. specializes in personalized cancer care technology solutions, including the Tumorgraft Technology Platform and Lumin Bioinformatics, aimed at enhancing oncology drug development and usage.
Symbol: CSBR
Recent Price: $8.62
Industry: Biotechnology
CEO: Dr. Ronnie Morris M.D.
Sector: Healthcare
Employees: 210
Address: One University Plaza, Hackensack, NJ 07601
Phone: 201 808 8400
Last updated: 2024-12-31
Immunome, Inc.
IMM-ONC-01, IMM-BCP-01
Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.
Symbol: IMNM
Recent Price: $10.28
Industry: Biotechnology
CEO: Dr. Clay B. Siegall Ph.D.
Sector: Healthcare
Employees: 78
Address: 665 Stockton Drive, Exton, PA 19341
Phone: 610 321 3700
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
Outlook Therapeutics, Inc.
ONS-5010
Outlook Therapeutics, Inc. is a late clinical-stage biopharmaceutical company focused on developing and commercializing monoclonal antibodies for ophthalmic indications, with its lead product candidate ONS-5010 in Phase-III clinical trial for treating wet age-related macular degeneration and other retina diseases.
About | About | Leadership | Directors | About | Contact | Careers | Careers | Careers | Jobs | About | About
Symbol: OTLK
Recent Price: $1.86
Industry: Biotechnology
CEO: Mr. C. Russell Trenary III
Sector: Healthcare
Employees: 24
Address: Building F, Iselin, NJ 08852
Phone: 609 619 3990
Leadership
- Randy Thurman, Executive Chairman
- Yezan Haddadin, Member of the Board of Directors
- Kurt J. Hilzinger, Member of the Board of Directors
- Julia A. Haller, MD, Member of the Board of Directors
- C. Russell Trenary III, President, Chief Executive Officer, and Member of the Board
- Lawrence A. Kenyon, Chief Financial Officer and Member of the Board
- Faisal G. Sukhtian, Executive Director
- Julian Gangolli, Member of the Board of Directors
- Gerd Auffarth, MD, Member of the Board of Directors
- Andong Huang, Vice President, Business Development
Last updated: 2024-12-31
PMV Pharmaceuticals, Inc.
PC14586
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule and tumor-agnostic therapies targeting p53 mutations in cancer, including lead product candidate PC14586.
Symbol: PMVP
Recent Price: $1.49
Industry: Biotechnology
CEO: Dr. David H. Mack Ph.D.
Sector: Healthcare
Employees: 63
Address: 8 Clarke Drive, Cranbury, NJ 08512
Phone: 609 642 6670
Last updated: 2024-12-31
Predictive Oncology Inc.
Personalized Cancer Therapies
Predictive Oncology Inc. is a knowledge-driven company focusing on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States, operating in four segments: Helomics, z PREDICTA, Soluble, and Skyline.
Symbol: POAI
Recent Price: $0.90
Industry: Medical - Instruments & Supplies
CEO: Mr. Raymond F. Vennare
Sector: Healthcare
Employees: 34
Address: 2915 Commers Drive, Eagan, MN 55121
Phone: 651 389 4800
Last updated: 2024-12-31
Personalis, Inc.
NeXT Platform
Personalis, Inc. is a cancer genomics company that provides sequencing and data analysis services for cancer therapy development and genetic research. Their products include NeXT Platform, NeXT Liquid Biopsy, NeXT Personal, NeXT Dx Test, and ACE platform, serving biopharmaceutical, academic, and government institutions.
About | Contact | Contact | Contact | Careers | Careers | Careers | About | About | Careers | About | About | About
Symbol: PSNL
Recent Price: $5.97
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher M. Hall
Sector: Healthcare
Employees: 223
Address: 1330 O’Brien Drive, Menlo Park, CA 94025
Phone: 650 752 1300
Last updated: 2024-12-31
Cullinan Oncology, Inc.
CLN-081
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Their lead candidate, CLN-081, is in a trial for treating non-small cell lung cancer. The company also has several preclinical products targeting various forms of cancer.
Symbol: CGEM
Recent Price: $12.20
Industry: Biotechnology
CEO: Mr. Nadim Ahmed
Sector: Healthcare
Employees: 85
Address: One Main Street, Cambridge, MA 02142
Phone: 617 410 4650
Last updated: 2024-12-31
IDEAYA Biosciences, Inc.
IDE397 and IDE196
IDEAYA Biosciences, Inc. is a precision medicine oncology company that focuses on developing targeted therapeutics for specific patient populations using molecular diagnostics. Key product candidates include IDE397 and IDE196, aimed at treating genetically defined cancers.
Symbol: IDYA
Recent Price: $24.93
Industry: Biotechnology
CEO: Mr. Yujiro S. Hata
Sector: Healthcare
Employees: 124
Address: 7000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 443 6209
Last updated: 2024-12-31
Marker Therapeutics, Inc.
Multi TAA-specific T cell technology
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing T cell-based immunotherapies and peptide-based vaccines for treating hematological malignancies and solid tumors in the US.
Contact | About | Management | Directors | About | Contact | Contact | Careers | About | About
Symbol: MRKR
Recent Price: $3.34
Industry: Biotechnology
CEO: Dr. Juan F. Vera M.D.
Sector: Healthcare
Employees: 8
Address: 3200 Southwest Freeway, Houston, TX 77027
Phone: 713 400 6400
Leadership
- David Eansor, President, Protein Sciences Segment, Bio-Techne Corporation
- Steve Elms, Managing Partner, Aisling Capital
- John R. Wilson, CEO, Wilson Wolf Manufacturing, Co-Founder Marker Therapeutics, Co-Founder AlloVir
- Juan F. Vera, Chief Executive Officer & Co-Founder, Marker Therapeutics, Co-Founder, AlloVir
- Katharine Knobil, M.D., Chief Medical Officer at Agilent Technologies, Inc.
Last updated: 2024-12-31
The Oncology Institute, Inc.
Medical Oncology Services
An oncology company providing medical oncology services in the United States, including clinical trials, radiation, outpatient stem cell transplants, and patient support, serving adult and senior cancer patients with 67 clinic locations.
About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: TOI
Recent Price: $0.32
Industry: Medical - Care Facilities
CEO: Dr. Daniel Virnich FACHE, M.B.A., M.D.
Sector: Healthcare
Employees: 800
Address: 18000 Studebaker Road, Cerritos, CA 90703
Phone: 213 760 1328
Last updated: 2024-12-31